248 related articles for article (PubMed ID: 28623627)
1. Clozapine-Induced Gastrointestinal Hypomotility: A 22-Year Bi-National Pharmacovigilance Study of Serious or Fatal 'Slow Gut' Reactions, and Comparison with International Drug Safety Advice.
Every-Palmer S; Ellis PM
CNS Drugs; 2017 Aug; 31(8):699-709. PubMed ID: 28623627
[TBL] [Abstract][Full Text] [Related]
2. Life-threatening clozapine-induced gastrointestinal hypomotility: an analysis of 102 cases.
Palmer SE; McLean RM; Ellis PM; Harrison-Woolrych M
J Clin Psychiatry; 2008 May; 69(5):759-68. PubMed ID: 18452342
[TBL] [Abstract][Full Text] [Related]
3. Reporting of clozapine-induced gastrointestinal hypomotility and factors associated with fatal outcomes in Canada: A pharmacovigilance database study.
Liu CL; Maruf AA; Bousman CA
Psychiatry Res; 2020 Aug; 290():113048. PubMed ID: 32474068
[TBL] [Abstract][Full Text] [Related]
4. Clozapine induced gastrointestinal hypomotility: A potentially life threatening adverse event. A review of the literature.
West S; Rowbotham D; Xiong G; Kenedi C
Gen Hosp Psychiatry; 2017 May; 46():32-37. PubMed ID: 28622812
[TBL] [Abstract][Full Text] [Related]
5. Focussing on the fundaments - assessing and treating Clozapine Induced Gastrointestinal Hypomotility.
Blackman G; Kapila A; Grosskopf CM; Dratcu L
Int J Psychiatry Clin Pract; 2020 Mar; 24(1):18-19. PubMed ID: 31910056
[No Abstract] [Full Text] [Related]
6. The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.
Every-Palmer S; Ellis PM; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H
CNS Drugs; 2017 Jan; 31(1):75-85. PubMed ID: 27826741
[TBL] [Abstract][Full Text] [Related]
7. Constipation screening in people taking clozapine: A diagnostic accuracy study.
Every-Palmer S; Inns SJ; Ellis PM
Schizophr Res; 2020 Jun; 220():179-186. PubMed ID: 32245597
[TBL] [Abstract][Full Text] [Related]
8. Clozapine-induced gastrointestinal hypomotility: presenting features and outcomes, UK pharmacovigilance reports, 1992-2017.
Handley SA; Every-Palmer S; Ismail A; Flanagan RJ
Br J Psychiatry; 2022 Feb; ():1-9. PubMed ID: 35164895
[TBL] [Abstract][Full Text] [Related]
9. Effects of Clozapine on the Gut: Cross-Sectional Study of Delayed Gastric Emptying and Small and Large Intestinal Dysmotility.
Every-Palmer S; Inns SJ; Grant E; Ellis PM
CNS Drugs; 2019 Jan; 33(1):81-91. PubMed ID: 30456745
[TBL] [Abstract][Full Text] [Related]
10. Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study.
Every-Palmer S; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H; Ellis PM
EBioMedicine; 2016 Mar; 5():125-34. PubMed ID: 27077119
[TBL] [Abstract][Full Text] [Related]
11. Clozapine and Gastrointestinal Hypomotility.
Cohen D
CNS Drugs; 2017 Dec; 31(12):1083-1091. PubMed ID: 29230675
[TBL] [Abstract][Full Text] [Related]
12. Clozapine-Associated Aspiration During Electroconvulsive Therapy.
Estime SR; Berg SM; Henry ME
J ECT; 2019 Jun; 35(2):133-134. PubMed ID: 30308569
[TBL] [Abstract][Full Text] [Related]
13. Clozapine-induced gastrointestinal hypomotility.
Vella-Brincat J; McKean A; Barclay M
Australas Psychiatry; 2011 Oct; 19(5):450-1. PubMed ID: 21995363
[No Abstract] [Full Text] [Related]
14. Gastrointestinal hypomotility: an under-recognised life-threatening adverse effect of clozapine.
Flanagan RJ; Ball RY
Forensic Sci Int; 2011 Mar; 206(1-3):e31-6. PubMed ID: 20719440
[TBL] [Abstract][Full Text] [Related]
15. [Underexposed, potential lethal gastrointestinal adverse events associated with clozapine use].
van Haaren PCF; Zwanenburg PR; Hendriks ER; Gerritse FL
Tijdschr Psychiatr; 2022; 64(6):377-381. PubMed ID: 35748149
[TBL] [Abstract][Full Text] [Related]
16. Beyond white blood cell monitoring: screening in the initial phase of clozapine therapy.
Cohen D; Bogers JP; van Dijk D; Bakker B; Schulte PF
J Clin Psychiatry; 2012 Oct; 73(10):1307-12. PubMed ID: 23140648
[TBL] [Abstract][Full Text] [Related]
17. Clozapine-associated myocarditis: a review of 116 cases of suspected myocarditis associated with the use of clozapine in Australia during 1993-2003.
Haas SJ; Hill R; Krum H; Liew D; Tonkin A; Demos L; Stephan K; McNeil J
Drug Saf; 2007; 30(1):47-57. PubMed ID: 17194170
[TBL] [Abstract][Full Text] [Related]
18. Constipation, ileus and medication use during clozapine treatment in patients with schizophrenia in Iceland.
Ingimarsson O; MacCabe JH; Sigurdsson E
Nord J Psychiatry; 2018 Oct; 72(7):497-500. PubMed ID: 30348045
[TBL] [Abstract][Full Text] [Related]
19. Treatment pathway and patterns of clozapine prescribing for schizophrenia in New Zealand.
Wheeler AJ
Ann Pharmacother; 2008 Jun; 42(6):852-60. PubMed ID: 18477732
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the epidemiology of clozapine-associated neutropenia among people on clozapine across Australia and Aotearoa New Zealand: a retrospective cohort study.
Northwood K; Myles N; Clark SR; Every-Palmer S; Myles H; Kisely S; Warren N; Siskind D
Lancet Psychiatry; 2024 Jan; 11(1):27-35. PubMed ID: 38040009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
